PB 104 of 2020

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 7)

National Health Act 1953

___________________________________________________________________________

I, PAUL HANSEN, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1) of the National Health Act 1953.

Dated    29 October 2020

PAUL HANSEN

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1               Name of Instrument

(1)           This Instrument is the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2020 (No. 7).

(2)           This Instrument may also be cited as PB 104 of 2020.

2               Commencement

This Instrument commences on 1 November 2020.

3               Amendments to National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019

Schedule 1 amends the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019.

Schedule 1 Amendments

[1]           Schedule 4, entry for Glyceryl trinitrate

omit:

[2]           Schedule 4, entry for Ketoconazole

omit:

[3]           Schedule 4, omit entry for Quinagolide